View Older Stories View More Recent Stories

May 31, 2018 05:00PM Hong Yu Appointed President of Biostage
May 25, 2018 04:05PM Dr. Wei Zhang Elected to Biostage's Board of Directors
May 10, 2018 08:00AM Biostage Reports 2018 First Quarter Financial Results
May 4, 2018 08:00AM Biostage to Host Conference Call to Discuss First Quarter 2018 Financial Results and Operations
Apr 2, 2018 08:00AM Biostage Reports 2017 Financial Results
Mar 29, 2018 04:10PM Biostage Names Distinguished Children's Hospital Executive James Shmerling to its Board of Directors
Mar 29, 2018 08:00AM Biostage awarded SBIR Fast-Track grant to develop Cellspan™ Esophageal Implant (CEI) as a novel treatment for esophageal atresia in pediatric patients
Mar 13, 2018 07:00AM Biostage Preclinical Study Results Published in New Report
Feb 20, 2018 07:00AM Biostage Closes $1 Million Private Placement
Feb 12, 2018 08:00AM Biostage Appoints to its Scientific Advisory Board Charles S. Cox, Jr., MD
Feb 7, 2018 04:15PM Biostage, Inc. Names Jason Chen Chairman of its Board of Directors
Feb 6, 2018 05:08PM Biostage to Host Conference Call to Provide Business Update
Jan 31, 2018 07:00AM Biostage Appoints to its Scientific Advisory Board Christine Finck, MD, Executive Vice President, Surgeon-in-Chief at Connecticut Children's Medical Center
Jan 3, 2018 09:00AM Biostage Closes $4.2 Million Private Placement
Dec 22, 2017 07:00AM Biostage Announces Reverse Stock Split Effective December 22, 2017
Dec 14, 2017 04:05PM Biostage Announces Binding Agreement For $4.0 Million Private Placement
Oct 12, 2017 05:08PM Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives
Oct 6, 2017 07:27AM Biostage (BSTG) to Move from Nasdaq to OTCQB Marketplace
Oct 6, 2017 07:25AM Biostage to Move to OTCQB Marketplace
Oct 2, 2017 07:05AM Biostage to Present at the 2017 Cell & Gene Meeting on the Mesa
Aug 14, 2017 07:00AM Biostage Reports 2017 Second Quarter Financial Results:
Aug 7, 2017 08:40AM Biostage (BSTG) Reports Use of Its Esophageal Implant Product Candidate
Aug 7, 2017 07:00AM Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Aug 4, 2017 07:00AM Biostage to Host Conference Call to Discuss Second Quarter 2017 Financial Results and Business Update
Jul 10, 2017 08:05AM Biostage (BSTG) Granted Continued Listing on Nasdaq
Jul 10, 2017 08:00AM Biostage Granted Continued Listing on Nasdaq
Jun 27, 2017 08:00AM Biostage Announces Agreement to Conduct $3.1 Million Private Placement at Market
Jun 19, 2017 08:06AM Biostage (BSTG) Says Positive Preclinical Data of Cellspan Esophageal Implant Presented at ISSCR
Jun 19, 2017 08:05AM Biostage Announces Positive Preclinical Data of Cellspan™ Esophageal Implant Presented at the International Society for Stem Cell Research 2017 Annual Meeting
Jun 14, 2017 10:07AM Biostage to Present at the 2017 Marcum MicroCap Conference
May 23, 2017 07:05AM Biostage to Present at the Cell and Gene Exchange 2017
May 22, 2017 07:14AM Biostage (BSTG) Receives Nasdaq Listing Determination; Plans to Request Hearing
May 22, 2017 07:05AM Biostage Announces Receipt of Nasdaq Listing Determination
May 11, 2017 07:00AM Biostage Reports 2017 First Quarter Financial Results and Provides Business Update
May 9, 2017 08:05AM Dr. Christine Finck of Connecticut Children's Medical Center, Presents Data in Poster Presentation from Collaboration with Biostage at the American Pediatric Surgical Association (APSA) 2017 Annual Me
May 5, 2017 08:05AM Biostage to Host 2017 First Quarter Update Conference Call
May 1, 2017 08:05AM Biostage to Present at the American Association for Thoracic Surgery Centennial Meeting
Apr 26, 2017 07:35AM Biostage to Participate at the Alliance for Regenerative Medicine's 5th Annual Cell & Gene Therapy Investor Day
Apr 18, 2017 08:01AM Biostage Appoints Stephen F. Badylak DVM, PhD, MD, as Co-Chairman of Scientific Advisory Board
Apr 6, 2017 07:14AM Biostage (BSTG) Highlights Positive Preclincal Data of Cellspan Esophageal Implant at Society For Biomaterials 2017 Conference
Apr 6, 2017 07:05AM Biostage Presents Positive Preclincal Data of Cellspan Esophageal Implant at Society For Biomaterials 2017 Annual Meeting and Exposition
Mar 28, 2017 07:05AM Biostage to Participate at the MassBio 2017 Annual Meeting
Mar 16, 2017 07:05AM Biostage Promotes Saverio La Francesca, M.D. to President
Mar 9, 2017 07:35AM Biostage Reports 2016 Financial Results and Provides Business Update
Mar 2, 2017 07:35AM Biostage to Host Fiscal Year 2016 Update Conference Call
Jan 6, 2017 07:35AM Biostage to Present at Biotech Showcase™ 2017
Dec 6, 2016 07:05AM Biostage to Participate at the 2016 World Stem Cell Summit and RegMed Capital Conference
Dec 1, 2016 07:08AM Biostage (BSTG) Granted Orphan Drug Status for Cellspan Esophageal Implant
Dec 1, 2016 07:05AM Biostage Receives FDA Orphan Drug Designation for Cellspan™ Esophageal Implant
Nov 22, 2016 07:05AM Nasdaq Provides Biostage with 180-day Period in Which to Regain Compliance with $1.00 Minimum Closing Bid Price Rule
View More Recent Stories View Older Stories